SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011740
Filing Date
2024-08-09
Accepted
2024-08-09 16:05:32
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sngx-20240630x10q.htm   iXBRL 10-Q 1668726
2 EX-31.1 sngx-20240630xex31d1.htm EX-31.1 18445
3 EX-31.2 sngx-20240630xex31d2.htm EX-31.2 18503
4 EX-32.1 sngx-20240630xex32d1.htm EX-32.1 8289
5 EX-32.2 sngx-20240630xex32d2.htm EX-32.2 11167
  Complete submission text file 0001558370-24-011740.txt   6383882

Data Files

Seq Description Document Type Size
6 EX-101.SCH sngx-20240630.xsd EX-101.SCH 35947
7 EX-101.CAL sngx-20240630_cal.xml EX-101.CAL 43787
8 EX-101.DEF sngx-20240630_def.xml EX-101.DEF 195422
9 EX-101.LAB sngx-20240630_lab.xml EX-101.LAB 357261
10 EX-101.PRE sngx-20240630_pre.xml EX-101.PRE 281166
58 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20240630x10q_htm.xml XML 983773
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 241192563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)